Centessa Pharmaceuticals Plc (CNTA)
39.76
+0.06
(+0.15%)
USD |
NASDAQ |
Jun 09, 16:00
39.76
0.00 (0.00%)
After-Hours: 20:00
Centessa Pharmaceuticals EPS Diluted (Quarterly) : -0.5152 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| Roivant Sciences Ltd. | 0.373 |
| Eli Lilly & Co. | 8.255 |
| Aptorum Group Ltd. | -0.0378 |
| Bicycle Therapeutics Plc | -0.8714 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -79.11M |
| Total Expenses (Quarterly) | 79.11M |
| Enterprise Value | 5.994B |
| Earnings Yield | -4.46% |
| Normalized Earnings Yield | -4.512 |